Richter Transformation clinical trials at UCSF

1 research study open to eligible people

Richter transformation occurs when chronic lymphocytic leukemia turns into a more aggressive cancer. UCSF is conducting studies with a drug called NX-1607 to assess its safety in patients. The trials also measure how this medication affects the cancer's growth.

Showing trials for

  • NX-1607 in Adults With Advanced Malignancies

    open to eligible people ages 18 years and up

    This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.

    San Francisco, California and other locations

Our lead scientists for Richter Transformation research studies include .

Last updated: